{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Spondylarthritis&page=4", "query": { "condition": "Spondylarthritis", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 290, "total_pages": 29, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Spondylarthritis&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Spondylarthritis&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T09:18:09.785Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03259074", "title": "Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ankylosing Spondylitis" ], "interventions": [ { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "GP2017 (adalimumab biosimilar)", "type": "BIOLOGICAL" }, { "name": "AIN457 150 mg", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 859, "start_date": "2017-11-30", "completion_date": "2021-11-29", "has_results": true, "last_update_posted_date": "2023-08-21", "last_synced_at": "2026-11-15T09:18:09.785Z", "location_count": 19, "location_summary": "Mesa, Arizona • Escondido, California • La Mesa, California + 16 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Escondido", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03259074" }, { "nct_id": "NCT02376790", "title": "Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Etanercept", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Placebo to Etanercept", "type": "DRUG" }, { "name": "Placebo to Methotrexate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 851, "start_date": "2015-03-03", "completion_date": "2018-07-06", "has_results": true, "last_update_posted_date": "2022-09-21", "last_synced_at": "2026-11-15T09:18:09.785Z", "location_count": 55, "location_summary": "Tuscaloosa, Alabama • Glendale, Arizona • Mesa, Arizona + 50 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02376790" }, { "nct_id": "NCT01583374", "title": "Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ankylosing Spondyloarthritis" ], "interventions": [ { "name": "Apremilast tablet 20 mg", "type": "DRUG" }, { "name": "Apremilast tablet 30 mg BID", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 490, "start_date": "2012-05-02", "completion_date": "2018-10-25", "has_results": true, "last_update_posted_date": "2020-05-12", "last_synced_at": "2026-11-15T09:18:09.785Z", "location_count": 20, "location_summary": "Peoria, Arizona • La Jolla, California • Palm Desert, California + 17 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Palm Desert", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Pinellas Park", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01583374" }, { "nct_id": "NCT07018206", "title": "Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Axial Spondylarthritis (axSpA)" ], "interventions": [ { "name": "Upadacitinib 15 MG [Rinvoq]", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CARE ARTHRITIS LTD.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2026-05", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-02-06", "last_synced_at": "2026-11-15T09:18:09.785Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT07018206" }, { "nct_id": "NCT05590247", "title": "Role of Intermittent Fasting in Psoriasis and Psoriatic Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Psoriasis", "Psoriatic Arthritis" ], "interventions": [ { "name": "Intermittent Fasting Diet", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2022-07-21", "completion_date": "2025-12-11", "has_results": false, "last_update_posted_date": "2026-04-06", "last_synced_at": "2026-11-15T09:18:09.785Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05590247" }, { "nct_id": "NCT07148414", "title": "A Study of SPY072 in Rheumatic Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis", "Psoriatic Arthritis", "Axial Spondyloarthritis", "Rheumatic Diseases", "Rheumatic Joint Disease", "PsA (Psoriatic Arthritis)", "AxSpA", "Rheumatologic Disease" ], "interventions": [ { "name": "SPY002-072", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Spyre Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 285, "start_date": "2025-08-21", "completion_date": "2028-03-31", "has_results": false, "last_update_posted_date": "2026-06-05", "last_synced_at": "2026-11-15T09:18:09.785Z", "location_count": 18, "location_summary": "Avondale, Arizona • Tucson, Arizona • Chula Vista, California + 14 more", "locations": [ { "city": "Avondale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Covina", "state": "California" }, { "city": "Tujunga", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07148414" }, { "nct_id": "NCT06004700", "title": "Improving Virtual Care of Arthritis: Integrating a Smartphone App Into the EHR for Improved Timeliness of Visits", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Arthritis", "Psoriatic Arthritis" ], "interventions": [ { "name": "Mobile Application", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 278, "start_date": "2024-04-11", "completion_date": "2026-10-01", "has_results": false, "last_update_posted_date": "2025-11-26", "last_synced_at": "2026-11-15T09:18:09.785Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06004700" }, { "nct_id": "NCT02008916", "title": "16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Spondylitis, Ankylosing" ], "interventions": [ { "name": "Secukinumab", "type": "DRUG" }, { "name": "Placebo secukinumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 226, "start_date": "2014-01-14", "completion_date": "2017-12-11", "has_results": true, "last_update_posted_date": "2019-01-08", "last_synced_at": "2026-11-15T09:18:09.785Z", "location_count": 14, "location_summary": "Mobile, Alabama • Mesa, Arizona • Peoria, Arizona + 11 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Upland", "state": "California" }, { "city": "Palm Harbor", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02008916" }, { "nct_id": "NCT05715463", "title": "Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rheumatoid Arthritis", "Palindromic Arthritis", "Juvenile Rheumatoid Arthritis", "Ankylosing Spondylitis", "Sacroiliitis", "Psoriatic Arthritis", "Mixed Connective Tissue Disease", "Lupus", "Enteropathic Arthropathies", "Systemic Sclerosis", "Sjogren's Syndrome", "Sicca Syndrome", "Inflammatory Arthritis", "Undifferentiated Connective Tissue Diseases" ], "interventions": [ { "name": "Resource sheets", "type": "OTHER" }, { "name": "Community Resource Specialist", "type": "OTHER" }, { "name": "Nurse Navigator", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 101, "start_date": "2023-03-01", "completion_date": "2026-12-01", "has_results": false, "last_update_posted_date": "2025-10-15", "last_synced_at": "2026-11-15T09:18:09.785Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05715463" }, { "nct_id": "NCT07223138", "title": "A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Arthritis, Psoriatic" ], "interventions": [ { "name": "Sonelokimab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MoonLake Immunotherapeutics AG", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1560, "start_date": "2025-11-13", "completion_date": "2028-02-04", "has_results": false, "last_update_posted_date": "2026-11-12", "last_synced_at": "2026-11-15T09:18:09.785Z", "location_count": 18, "location_summary": "Avondale, Arizona • Mesa, Arizona • Phoenix, Arizona + 15 more", "locations": [ { "city": "Avondale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT07223138" } ] }